# Circulating Tumor DNA in Patients at High Risk for Lung Cancer

> **NCT02715102** · — · TERMINATED · sponsor: **Pathway Genomics** · enrollment: 39 (actual)

## Conditions studied

- Cancer of the Lung
- Lung Cancer
- Lung Neoplasms
- Adenocarcinoma of the Lung
- Non Small Cell Carcinoma of the Lung
- Small Cell Carcinoma of the Lung

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02715102
- **Lead sponsor:** Pathway Genomics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** Patient accrual was slow due to exclusion of patients with prior cancers
- **Last updated:** 2017-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02715102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02715102, "Circulating Tumor DNA in Patients at High Risk for Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02715102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*